Clinical Trial Update: Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing enzastaurin plus fulvestrant versus placebo plus fulvestrant in breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enzastaurin (enzastaurin)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-11-01